No Detail Found!

Molecular Modelling, Drug Design and Binding Evaluation of New Celecoxib Derivatives as Cyclooxygenase-2 Inhibitors

Author(s)
BASMA M. ABD RAZIK Department of Pharmaceutical Chemistry, College of Pharmacy, Mustansiriyah University,10001, Baghdad, Iraq
MOHAMMED ODAY EZZAT Department of Chemistry, College of Education for Women, University of Anbar,31001, Ramadi, Anbar,Iraq
SAMINA KHAN YUSUFZAI Faculty of Natural Science and Sustainability, University College Sabah Foundation,88100,Sembulan, Kota Kinabalu, Sabah,Malaysia
Abstract
Celecoxib is the most effective nonsteroidal anti-inflammatory drug (NSAID) used as selective targeted cyclooxygenase-2 (COX-2) inhibitor. Although it remarkable used to treat pain and inflammation in rheumatoid arthritis, painful menstruation, acute pain in adults and osteoarthritis, but serious side effects of celecoxib includes gastrointestinal bleeding, kidney failure, heart attacks, nausea, abdominal pain, and diarrhea. In this work, a total of 18 celecoxib analogues were docked inside cyclooxygenase-2 (COX-2) enzyme crystal structure to calculate the binding potency of each analogue inside active site. Molecular modeling and In silico prediction of ADMET properties approaches were applied and the twenty most effective celecoxib analogues were selected with docking binding range (-14.91 to -13.24) kcal/mol.
Publication Details
Page(s) 983-988
DOI DOI not available
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 14, Issue: 3, Year: 2020

Request the full text from PASTIC

Keywords
drug design, new celecoxib derivatives, inhibitors
0

Citations

0

Downloads

47

Views